Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfimeprase in Occluded CVAD (SONOMA-3)
NCT00322270Phase 3Completed
- Sponsor
- Oruka Therapeutics
- Start
- Jan 2006
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alfimeprase in catheter occlusion, sponsored by Oruka Therapeutics. Started Jan 2006; status: completed.
02
Drugs
alfimeprase
03
Conditions
catheter occlusion
Beyond the preview
Go deeper on NCT00322270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322270.